In this article (11 sections)
Frontal fibrosing alopecia, usually shortened to FFA, is a scarring hair loss that pushes the frontal hairline backward in a smooth, band-like recession. It was first described in a small group of postmenopausal women in 1994 (Kossard S, Arch Dermatol, 1994), and dermatology clinics around the world have reported sharply rising numbers of cases since then. What makes FFA distinct from an ordinary receding hairline is the underlying biology: the follicles along the receding edge are not miniaturizing, they are being destroyed by inflammation and replaced with scar tissue. That difference is the whole reason this page exists, because it changes both the urgency and the kind of care that helps.
This page covers what FFA is, the signs that distinguish it from pattern hair loss, who tends to develop it, why it calls for in-person dermatology rather than telehealth-only care, and what evaluation and treatment usually involve.
What FFA is
FFA is a member of the scarring (cicatricial) alopecia family, and most dermatologists consider it a clinical variant of a broader condition called lichen planopilaris (Vañó-Galván S et al., J Am Acad Dermatol, 2014). In these disorders, a band of lymphocytic inflammation gathers around the upper part of the follicle, damages the stem cells that let a follicle regenerate, and gradually swaps the follicle out for fibrous tissue. Once that scarring is complete, the small pore on the scalp where the hair used to emerge closes over, and no medication will regrow hair in that spot.
This is fundamentally different from androgenetic alopecia, the pattern hair loss most people picture. In pattern loss the follicle shrinks but survives, which is why medical treatment can coax it back into producing thicker hair. In FFA the follicle is lost for good. The clinical goal is therefore not regrowth but halting the inflammation before it claims more of the hairline.
How FFA presents
The recession in FFA has a recognizable look. Rather than the M-shaped thinning of a receding hairline from pattern loss, FFA produces a fairly uniform band of recession across the frontal and frontotemporal hairline. Several features point specifically toward FFA:
- A pale, smooth band of skin where the hairline used to be, which often looks lighter than the sun-exposed forehead below it because that strip of scalp has been covered by hair for decades
- Loss of the small follicular openings in the receded zone, so the skin looks featureless under magnification
- A "lonely hair sign," where one or a few isolated terminal hairs are left stranded in the band of bare skin
- Perifollicular redness and small rough spots (follicular hyperkeratosis) at the active edge, where the inflammation is currently working
- Eyebrow thinning or loss, which is present in a large share of patients and frequently appears before the hairline change is obvious
That last sign is worth emphasizing. Eyebrow loss precedes scalp recession in a meaningful number of cases, so a woman who notices her eyebrows thinning along with subtle hairline change should treat the combination as a reason to be seen, not as two unrelated cosmetic issues. Some patients also lose other facial and body hair or develop small skin-colored bumps on the face, reflecting the same follicular inflammation away from the scalp.
Who develops FFA
The clear majority of people diagnosed with FFA are postmenopausal women, which has driven longstanding speculation about a hormonal trigger, although no hormonal cause has been confirmed. The condition does occur in premenopausal women and, less often, in men, where eyebrow and sideburn involvement can be the first clue.
Large case series have looked for associated factors. The multicenter review of 355 patients by Vañó-Galván and colleagues found that early menopause and a personal or family history of autoimmune conditions, particularly thyroid disease, appeared more often than expected (Vañó-Galván S et al., J Am Acad Dermatol, 2014). Researchers have also examined environmental exposures, including leave-on facial products and sunscreens, as possible contributors to the worldwide rise in cases. Those associations are debated and not established as causes, so they are best understood as active areas of study rather than settled explanations. The honest summary is that FFA is probably driven by a combination of genetic susceptibility, hormonal change, and immune activity, with the precise trigger still unknown.
Why this requires in-person dermatology
Most pattern hair loss can be assessed safely by telehealth, because a clinician can recognize the typical pattern from photographs and history and recommend standard medication. FFA is a different situation in several concrete ways.
The diagnosis usually needs hands-on examination and often a scalp biopsy. A dermatologist uses trichoscopy, a magnified look at the scalp, to see the loss of follicular openings and the perifollicular inflammation at the active border, and a small punch biopsy taken from that border confirms the lichenoid scarring pattern under the microscope. Photographs alone cannot reliably separate FFA from a traction-related hairline change or ordinary pattern recession.
The treatment is not the standard pattern-baldness regimen, and it has to be matched to how active the disease is and monitored over time. Suppressing inflammation, deciding when therapy can be tapered, and tracking whether the hairline has stabilized all depend on serial in-person examination. And the cost of getting it wrong is real: every month that active inflammation goes unchecked is more follicles crossing the line from recoverable to permanently scarred.
For these reasons, Curekey's clinicians, like most telehealth physicians who handle hair-loss assessments, refer suspected scarring alopecia to in-person dermatology for diagnosis and primary management. We can sometimes play a supporting role for any adjacent pattern thinning that falls within the scope of telehealth, but the frontal fibrosing alopecia itself is best managed in person.
What evaluation usually involves
A first dermatology visit for suspected FFA typically includes:
- A history of how and when the hairline change began, and whether the eyebrows or other hair have thinned
- A history of any autoimmune or thyroid conditions, the timing of menopause, and family history
- Trichoscopy of the active hairline border to look for loss of follicular openings, perifollicular redness, and scaling
- A small punch biopsy from the active edge, processed so a pathologist can confirm the scarring pattern and rule out other diagnoses
- Photographs and hairline measurements to establish a baseline, since the most important treatment question is whether the recession is still advancing
Bloodwork, including thyroid studies, is sometimes ordered given the recognized association with autoimmune thyroid disease.
What treatment aims to do
The goal of FFA treatment is to stop the disease from advancing, not to recover the hairline that has already scarred. When the inflammation is brought under control early, many patients hold their position for years and keep the hair they still have.
Reported treatment approaches, drawn from case series rather than large randomized trials, include:
- Topical and intralesional corticosteroids applied along the active border to calm local inflammation
- Topical calcineurin inhibitors as a steroid-sparing anti-inflammatory option
- Oral 5-alpha-reductase inhibitors (finasteride or dutasteride), which in the large multicenter review were associated with stabilization or improvement in a majority of treated patients, though the mechanism in a scarring alopecia is not fully understood (Vañó-Galván S et al., J Am Acad Dermatol, 2014)
- Hydroxychloroquine or other systemic immunomodulators for more active or refractory disease
- Adjunctive minoxidil to support any non-scarred follicles, which does not treat the underlying scarring process
Because the evidence base is observational, dermatologists individualize the plan to disease activity and tolerance, and they track response over months. Surgical hair restoration and eyebrow transplantation are sometimes considered, but only after the disease has been demonstrably inactive for an extended period, since grafting into an actively inflamed area risks losing the new follicles to the same process.
When to seek evaluation
An in-person dermatology evaluation is worth scheduling sooner rather than later if any of the following apply:
- The frontal hairline has receded in a smooth band over months, especially if the receded skin looks pale or shiny
- The eyebrows have thinned or disappeared, particularly alongside any hairline change
- There is redness, scaling, or small rough bumps right at the edge of the hairline
- Isolated single hairs are left standing in an otherwise bare strip of hairline
- New hairline change has appeared around or after menopause, or alongside a known thyroid or autoimmune condition
There is no clinical advantage to waiting until the recession is dramatic. With FFA, earlier evaluation directly protects more of the hairline.
How FFA is distinguished from other diagnoses
Several conditions affect the frontal hairline and call for different management:
- Androgenetic alopecia: pattern recession that preserves follicular openings, with no pale scarred band and no eyebrow loss.
- Traction alopecia: hairline loss from chronic styling tension, often with a preserved fringe of fine hairs at the very front, the opposite of FFA's uniform recession.
- CCCA: a scarring alopecia that starts at the crown rather than the frontal hairline.
- Telogen effluvium: diffuse temporary shedding across the whole scalp, not a focal band.
- Alopecia areata: autoimmune patchy loss with sharply defined borders and preserved follicular openings.
When the picture is not clear from examination, a biopsy is the single most decisive test.
Considering medical assessment
Frontal fibrosing alopecia is one of the hair-loss diagnoses where the right next step is often in-person dermatology rather than telehealth. Curekey is a HIPAA-compliant platform where licensed U.S. physicians review each case, and our standard process is to flag suspected scarring alopecia for in-person dermatologic care. For adjacent pattern thinning or other concerns that fall within the scope of telehealth, we can help with the medical pieces that fit. For FFA itself, an in-person dermatologist remains the primary clinician.
If you are unsure where your situation falls, the how it works page describes our assessment process, and an initial review can help clarify whether your case is one we can support directly or one we should route to in-person care.
Related reading
- Hair loss overview: the pillar covering causes, patterns, and treatment options.
- Women and hair loss: hormonal, medical, and life-stage contributors to female hair thinning.
- CCCA: the other common scarring alopecia, which begins at the crown.
- Traction alopecia: a hairline diagnosis frequently confused with FFA, with an opposite fringe pattern.
- Receding hairline: pattern-related frontal thinning and how it differs from scarring recession.
- Glossary of hair loss terms: definitions for cicatricial alopecia, trichoscopy, lichen planopilaris, and related references.
- How Curekey works: clinical assessment process and what to expect.
